The director of the hospital’s pain medicine center, Jianxiong An, has discovered through years of research and clinical practice that the treatment of osteonecrosis of the femoral head with precise injections under imaging guidance and systemic triple oxygen intervention is highly effective. Femoral head necrosis has always been a difficult problem for the global medical community, especially since the introduction of hormones and their widespread use, the incidence of this disease has gradually increased. Femoral head necrosis is caused by hormones, alcohol abuse and trauma, and is characterized by inflammation, edema, exudation, ischemia and necrosis of the femoral head, mainly manifesting as hip pain and limited movement, and can lead to disability if not treated in time. The most effective treatment is artificial arthroplasty, and there is no effective conservative treatment available. An introduced that the combination of imaging and computer technology provides unprecedentedly superior conditions for high-quality minimally invasive interventions. With the guidance of these technologies, doctors can transform the previous blind puncture into visualized and precise interventions, thus achieving maximum efficacy with minimal damage and side effects. Through the use of this technology, the Aviation General Hospital has now cured more than ten patients. An also believes that abnormalities in the systemic internal environment are also an important basis for the pathogenesis of localized lesions of the femoral head, because three of the four major causes of femoral head necrosis (hormone use, alcoholism and decompression sickness) are systemic factors, and the mechanisms of action of blood or rectal trioxides, such as anti-inflammatory, immune boosting and metabolic promotion, will undoubtedly contribute to the treatment of localized lesions of the femoral head. The work of Jianxiong An’s group has demonstrated that systemic modulation therapy can significantly improve the durability of the efficacy of femoral head necrosis treatment.